Picture Berlin Partner Voices from Berlin-Brandenburg Georg Duda 650x200px
Collaboration › Details

Ionis Pharmaceuticals–Bank of America: investor conference, 202109 supply service Ionis presents at BofA Global Healthcare Conference


Period Period 2021-09-13
Organisations Partner, 1st Ionis Pharmaceuticals Inc. (Nasdaq: IONS)
  Group Ionis Pharmaceuticals (Group)
  Partner, 2nd Bank of America Securities LLC (BofA Securities)
  Group Bank of America (BofA) (Group)
Products Product Bank of America Merrill Lynch Global Healthcare Conference 2021 DIGITAL (London)
  Product 2 RNA-targeting small molecule drugs (rSMs)

Ionis Pharmaceuticals, Inc.. (9/2/21). "Press Release: Ionis to Present at Upcoming Virtual Investor Conferences". Carlsbad, CA.

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will present a company overview at the following virtual investor conferences:

> 2021 Wells Fargo Healthcare Conference on Friday, September 10, 2021

> Morgan Stanley 19th Annual Global Healthcare Conference on Monday, September 13, 2021

> Bank of America Global Healthcare Conference 2021 on Wednesday, September 15, 2021

The above listed dates are subject to change. Details on presentation times or changes to presentation dates can be found on the Company's website. Please check for the latest information.

A live webcast of the presentations will be available on the Investors & Media section of the Ionis website. The replays will be available within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals

For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading neurological and cardiometabolic franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming one of the most successful biotechnology companies.

To learn more about Ionis visit and follow us on twitter @ionispharma.

Ionis Pharmaceuticals Investor Contact: 760-603-2331 or Ionis Pharmaceuticals Media Contact: 760-603-4679

Record changed: 2021-09-12


Picture [iito] [LSE] Business Portal 650x200px

More documents for Ionis Pharmaceuticals (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group BioPharm Amercia 2022 Boston 650x300px

» top